SCHEMBL7651934

SCHEMBL7651934

CSCCC(NC(=O)CN1C(=O)N(CCCc2c[nH]cn2)C(=O)C1(C)c1cccc2ccccc12)C(=O)O

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FNTA P49354 18/20 0.77
FNTB P49356 18/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656698 0.96 FNTA (0.77) FNTAFNTB
SCHEMBL7653520 0.93 FNTA (0.78) FNTAFNTB
SCHEMBL7656283 0.89 FNTA (0.77) FNTAFNTB
SCHEMBL8123495 0.84 FNTA (0.77) FNTAFNTB
SCHEMBL7650677 0.82 FNTA (0.61) FNTAFNTB
SCHEMBL7653591 0.82 FNTA (0.72) FNTAFNTB
SCHEMBL8121014 0.81 FNTA (0.72) FNTAFNTB
SCHEMBL7650169 0.81 FNTA (1.00) FNTAFNTB
SCHEMBL7660847 0.80 FNTA (0.71) FNTAFNTB
SCHEMBL7650126 0.79 FNTA (0.68) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384061-B1 HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS LG CHEMICAL LTD. (KR) 2002-05-07 US claimed
EP-1000036-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LIMITED (KR) 2000-05-17 EP claimed
WO-1999005117-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LTD. (KR) 1999-02-04 WO claimed
US-6384061-B1 HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS LG CHEMICAL LTD. (KR) 2002-05-07 US disclosed